Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 6/20 | 0.49 |
| ▸ | REN | P00797 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | PEPD | P12955 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | HRH1 | P35367 | 1/20 | 0.49 |
| ▸ | THPO | P40225 | 1/20 | 0.49 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.49 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1955445 | 1.00 | RAB9A (0.51) | RAB9AACERENLMNAHSD17B10 | |
| SCHEMBL3138576 | 1.00 | RAB9A (0.51) | RAB9AACERENLMNAHSD17B10 | |
| SCHEMBL3711047 | 0.95 | CNR1 (0.47) | RAB9AACERENLMNAHSD17B10 | |
| SCHEMBL3711045 | 0.95 | CNR1 (0.47) | RAB9AACERENLMNAHSD17B10 | |
| SCHEMBL5702070 | 0.89 | RAB9A (0.42) | RAB9AACERENLMNAHSD17B10 | |
| SCHEMBL11543098 | 0.89 | RAB9A (0.42) | RAB9AACERENLMNAHSD17B10 | |
| SCHEMBL5701940 | 0.89 | RAB9A (0.42) | RAB9AACERENLMNAHSD17B10 | |
| SCHEMBL13502493 | 0.87 | ACE (0.47) | RAB9AACERENLMNAHSD17B10 | |
| SCHEMBL13502383 | 0.87 | ACE (0.47) | RAB9AACERENLMNAHSD17B10 | |
| SCHEMBL12426957 | 0.86 | F2 (0.49) | RAB9AACERENLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100076015-A1 | Aminopyridine Derivatives | VANTIA LIMITED (GB) | 2010-03-25 | — | — | US | claimed |
| WO-2009133348-A1 | AMINOPYRIDINE DERIVATIVES | VANTIA LIMITED (GB) | 2009-11-05 | — | — | WO | claimed |
| EP-3155436-B1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LTD (GB) | 2023-08-30 | — | — | EP | disclosed |
| US-20170146549-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
| EP-3155436-A1 | ISOBARIC MASS LABELS | Electrophoretics Limited (GB) | 2017-04-19 | — | — | EP | disclosed |
| WO-2015189413-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2015-12-17 | — | — | WO | disclosed |
| US-20100137306-A1 | HETEROCYCLIC TRPV1 RECEPTOR LIGANDS | PURDUE PHARMA L.P. | 2010-06-03 | — | — | US | disclosed |
| US-20100076015-A1 | Aminopyridine Derivatives | VANTIA LIMITED (GB) | 2010-03-25 | — | — | US | disclosed |
| WO-2009133348-A1 | AMINOPYRIDINE DERIVATIVES | VANTIA LIMITED (GB) | 2009-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076015-A1 | Aminopyridine Derivatives | CHRM1, ARG1, ARG2 | RAB9A 1902/4885ACE 763/4885REN 1899/4885 |
| US-20100137306-A1 | HETEROCYCLIC TRPV1 RECEPTOR LIGANDS | TRPV1, TRPA1, TRPV2 | RAB9A 1368/4885ACE 4382/4885REN 2519/4885 |
| US-20170146549-A1 | ISOBARIC MASS LABELS | SRMS, PTMS, QPCTL | RAB9A 891/4885ACE 1047/4885REN 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.